Glucocorticoid treatment and impaired mood, memory and metabolism in people with diabetes: The Edinburgh Type 2 Diabetes Study

European Journal of Endocrinology

Volumn 166, Issue 5, 2012, Pages 861-868

  Reynolds, Rebecca M ^a   Labad, Javier ^a,b   Sears, Alison V ^c   Williamson, Rachel M ^c   Strachan, Mark W J ^c   Deary, Ian J ^d   Lowe, Gordon D O ^e   Price, Jackie F ^d   Walker, Brian R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b Reus   (Spain)

^c WESTERN GENERAL HOSPITAL   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID;

ADULT; AGED; ANKLE BRACHIAL INDEX; ANXIETY DISORDER; ARTHRITIS; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; BODY FAT DISTRIBUTION; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; DISEASE ASSOCIATION; DRUG USE; FATTY LIVER; FEMALE; GASTROINTESTINAL DISEASE; GLYCEMIC CONTROL; HUMAN; HYPERTENSION; INFLAMMATION; LEUKOCYTE COUNT; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEMORY DISORDER; MENTAL PERFORMANCE; METABOLIC DISORDER; MOOD DISORDER; NEUTROPHIL COUNT; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RHEUMATIC POLYMYALGIA; SEX DIFFERENCE; SIDE EFFECT; SKIN DISEASE; SMOKING HABIT;

AGED; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOCORTICOIDS; GLUCOSE METABOLISM DISORDERS; HUMANS; MALE; MEMORY DISORDERS; MIDDLE AGED; MOOD DISORDERS; PROSPECTIVE STUDIES; SCOTLAND; TREATMENT OUTCOME;

EID: 84862074259     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-12-0041     Document Type: Article

References (27)

1. van Staa TP, Leufkens HG, Abenhaim L, Begaud B, Zhang B & Cooper C. Use of oral corticosteroids in the United Kingdom. Quarterly Journal of Medicine 2000 93 105-111. (doi:10.1093/ qjmed/93.2.105)
2. Andrews RC & Walker BR. Glucocorticoids and insulin resistance: old hormones, new targets. Clinical Science 1999 96 513-523. (doi:10.1042/ CS19980388)
3. Delaunay F, Khan A, Cintra A, Davani B, Ling Z-C, Andersson A, Ostenson CG, Gustafsson J, Efendic S & Okret S. Pancreatic beta cells are important targets for the diabetogenic effects of glucocorticoids. Journal of Clinical Investigation 1997 100 2094-2098. (doi:10.1172/JCI119743)
4. Souverain PC, Berard A, van Staa TP, Cooper C, Leufkens HGM & Walker BR. Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population-based case-control study. Heart 2004 90 859-865. (doi:10.1136/hrt.2003.020180)
5. Wei L, MacDonald TM & Walker BR. Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease. Annals of Internal Medicine 2004 141 764-770.
6. Brown ES. Effects of glucocorticoids on mood, memory, and the hippocampus. Treatment and preventive therapy. Annals of the New York Academy of Sciences 2009 1179 41-55. (doi:10.1111/j.1749-6632.2009.04981.x)
7. Pariante CM. The glucocorticoid receptor: part of the solution or part of the problem? Journal of Psychopharmacology 2006 20 79-84. (doi:10.1177/ 1359786806066063)
8. Starkman MN, Giordani B, Berent S, Schork MA & Schteingart DE. Elevated cortisol levels in Cushing's disease are associated with cognitive decrements. Psychosomatic Medicine 2001 63 985-993. (Pubitemid 33101385)
9. Haffner SM, Lehto S, Ronnemaa T, Pyorala K & Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. New England Journal of Medicine 1998 339 229-234. (doi:10.1056/NEJM199807233390404)
10. Labad J, Price JF, StrachanMW, Fowkes FG, Ding J, Deary IJ, Lee AJ, Frier BM, Seckl JR,Walker BR & Reynolds RM & Edinburgh Type 2 Diabetes study investigators. Symptoms of depression but not anxiety are associated with central obesity and cardiovascular disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetologia 2010 53 467-471. (doi:10.1007/s00125-009-1628-9)
11. Reynolds RM, StrachanMW, Labad J, Lee AJ, Frier BM, Fowkes FG, Mitchell R, Seckl JR, Deary IJ, Walker BR & Price JF & Edinburgh Type 2 Diabetes study investigators. Morning cortisol levels and cognitive abilities in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes Care 2010 33 714-720. (doi:10.2337/dc09-1796)
12. Blackburn D, Hux J & Mamdani M. Quantification of the risk of corticosteroid-induced diabetes mellitus among the elderly. Journal of General Internal Medicine 2002 17 717-720. (doi:10.1046/j.1525-1497.2002.10649.x)
13. Gulliford MC, Charlton J & Latinovic R. Risk of diabetes associated with prescribed glucocorticoids in a large population. Diabetes Care 2006 29 2728-2729. (doi:10.2337/dc06-1499)
14. Gurwitz JH, Bohn RL, Glynn RJ, Monane M, Mogun H & Avorn J. Glucocorticoids and the risk for initiation of hypoglycemic therapy. Archives of Internal Medicine 1994 154 97-101. (doi:10.1001/archinte.1994.00420010131015)
15. Price JF, Reynolds RM, Mitchell RJ, Williamson RM, Fowkes FG, Deary IJ, Lee AJ, Frier BM, Hayes PC & Strachan MW. The Edinburgh Type 2 Diabetes Study: study protocol. BMC Endocrine Disorders 2008 8 18. (doi:10.1186/1472- 6823-8-18)
16. Rose GA. The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bulletin of the World Health Organisation 1962 27 645-658.
17. Gale CR, Allerhand M, Sayer AA, Cooper C, Dennison EM, Starr JM, Ben-Shlomo Y, Gallacher JE, Kuh D & Deary IJ & HALCyon Study Team. The structure of the Hospital Anxiety and Depression Scale in four cohorts of community-based, healthy older people: the HALCyon program. International Psychogeriatrics 2010 22 559-571. (doi:10.1017/S1041610210000256)
18. Bjelland I, Dahl AA, Haug TT & Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. Journal of Psychosomatic Research 2002 52 69-77. (doi:10.1016/S0022-3999(01)00296-3)
19. Reynolds RM, Labad J, Strachan MW, Braun A, Fowkes FG, Lee AJ, Frier BM, Seckl JR, Walker BR & Price JF & Edinburgh Type 2 Diabetes Study (ET2DS) Investigators. Elevated fasting plasma cortisol is associated with ischemic heart disease and its risk factors in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Journal of Clinical Endocrinology and Metabolism 2010 95 1602-1608. (doi:10.1210/jc.2009-2112)
20. Williamson RM, Price JF, Glancy S, Perry E, Nee LD, Hayes PC, Frier BM, Van Look LA, Johnston GI, Reynolds RM & StrachanMW & Edinburgh Type 2 Diabetes study investigators. Prevalence of and risk factors for hepatic steatosis and nonalcoholic fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes Care 2011 34 1139-1144. (doi:10.2337/ dc10-2229)
21. Williamson RM, Perry E, Glancy S, Marshall I, Gray C, Nee LD, Hayes PC, Forbes S, Frier BM, Johnston GI, Lee AJ, Reynolds RM, Price JF, MW Strachan & Edinburgh Type 2 Diabetes study investigators. The use of ultrasound to diagnose hepatic steatosis in type 2 diabetes: intra- and interobserver variability and comparison with magnetic resonance spectroscopy. Clinical Radiology 2011 66 434-439. (doi:10.1016/j.crad.2010.09.021)
22. Walker BR. Glucocorticoids and cardiovascular disease. European Journal of Endocrinology 2007 157 545-559. (doi:10.1530/EJE-07-0455)
23. Rockall AG, Sohaib SA, Evans D, Kaltsas G, Isidori AM, Monson JP, Besser GM, Grossman AB & Reznek RH. Hepatic steatosis in Cushing's syndrome: a radiological assessment using computed tomography. European Journal of Endocrinology 2003 149 543-548. (doi:10.1530/eje.0.1490543)
24. Katon W, Von Korff M, Ciechanowski P, Russo J, Lin E, Simon G, Ludman E, Walker E, Bush T & Young B. Behavioral and clinical factors associated with depression among individuals with diabetes. Diabetes Care 200427914-920. (doi:10.2337/diacare.27. 4.914)
25. Taylor VA, Ellenbogen MA, Washburn D & Joober R. The effects of glucocorticoids on the inhibition of emotional information: a dose-response study. Biological Psychology 2011 86 17-25. (doi:10.1016/j.biopsycho.2010.10. 001)
26. Finkel D, Reynolds CA, McArdle JJ & Pedersen NL. Age changes in processing speed as a leading indicator of cognitive aging. Psychology and Aging 2007 22 558-568. (doi:10.1037/0882- 7974.22.3.558)
27. Stranahan AM, Arumugam TV, Cutler RG, Lee K, Egan JM & Mattson MP. Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons. Nature Neuroscience 2008 11 309-317. (doi:10.1038/nn2055)